Financing: Page 3

Accent Therapeutics raises $75M in series C funding round
By LabPulse.com staff writers
Biopharmaceutical company Accent Therapeutics has raised $75 million in a series C financing round, with the aim of using the funds to advance two of its precision oncology candidates to clinical trials.
January 23, 2024
Research Money Social
Myrobalan Therapeutics completes $24M series A financing round
By LabPulse.com staff writers
Biotech company Myrobalan Therapeutics completed a $24 million series A financing round Wednesday.
January 11, 2024
Research Money Social
Biotech startup Moonwalk Biosciences launches with $57M in financing
By LabPulse.com staff writers
New biotechnology startup Moonwalk Biosciences has launched with the completion of $57 million in seed and series A financing to advance its epigenetic profiling and engineering technology platform and therapeutics for a range of conditions.
January 4, 2024
Dna Genome Gene Targeted Social
Parse Biosciences raises $50M with Series C financing round, debt facility
By LabPulse.com staff writers
Single-cell sequencing firm Parse Biosciences said in a statement that it has raised $50 million through a Series C financing round combined with a debt facility from Horizon Technology Finance.
December 14, 2023
Research Money Social
Cytovale raises $84M in series C funding
By LabPulse.com staff writers
Medical technology firm Cytovale has raised $84 million in a series C financing round that the firm says it will use to expand the commercialization of its 10-minute IntelliSep test.
November 16, 2023
Money Hundred Bills Social
GeneDx to eliminate 10% of workforce, secures $75M in financing
By LabPulse.com staff writers
As part of a plan to reduce its annual operating expenses by approximately $40 million, GeneDx said it will lay off approximately 10% of its workforce.
October 31, 2023
Business Graph Money Stocks Social
Oxford Nanopore to receive $84.6M investment from BioMĂ©rieux, enters collaboration with Mayo Clinic
By LabPulse.com staff writers
Oxford Nanopore is receiving a strategic investment of 70 million pounds ($84.6 million) from in vitro diagnostics (IVD) company BioMĂ©rieux. In addition, the firm has entered a collaboration with the Mayo Clinic on test development.
October 19, 2023
Research Money Social
U.K. startup Sparta Biodiscovery secures deal with Sartorius
By Matt Limb
London-based Sparta Biodiscovery has secured up to 3.5 million pounds ($4.3 million) in funding for the commercial rollout of its nanoparticle analyzers, which are used in the development of advanced medicines.
October 13, 2023
Laboratory Software Social
Harbinger Health raises $140M in series B funding
By LabPulse.com staff writers
Biotech company Harbinger Health has raised $140 million in a series B funding round.
September 29, 2023
Artificial Intelligence Drug Design Funding Social
Day Zero Diagnostics to use $16M in funding to improve management of antibiotic-resistant infections
By Nick Paul Taylor
Day Zero Diagnostics recently raised $16 million to fund the application of whole-genome sequencing and artificial intelligence to antibiotic-resistant infections, facilitating the firm’s goal of changing how infectious diseases are diagnosed.
September 28, 2023
Dna Sequencing2
Rome Therapeutics raises $72M in series B financing
By Matt Limb
Biotech company Rome Therapeutics has raised a further $72 million in financing to develop medicines for autoimmune diseases and continue its exploration of the “dark genome.”
September 20, 2023
Dna Genome Gene Targeted Social
Day Zero Diagnostics completes $16M financing round
By LabPulse.com staff writers
Day Zero Diagnostics has completed a $16 million financing round, executed as a convertible note.
September 20, 2023
Research Money Social
Previous Page
Page 3 of 9
Next Page